Skip to Content

Branded Legacy Inc BLEG

Morningstar Rating
$0.00 0.00 (7.89%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

BLEG is trading at a 396% premium.
Price
$0.00
Fair Value
$5.23
Uncertainty
Extreme
1-Star Price
$3.24
5-Star Price
$2.14
Economic Moat
Chbnt
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if BLEG is a good fit for your portfolio.

News

Trading Information

Previous Close Price
$0.00
Day Range
$0.000.00
52-Week Range
$0.000.01
Bid/Ask
$0.00 / $0.00
Market Cap
$1.25 Mil
Volume/Avg
14.8 Mil / 12.4 Mil

Key Statistics

Price/Earnings (Normalized)
Price/Sales
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

Branded Legacy Inc is working towards horizontal and vertical integration within the agricultural and pharmaceutical biotechnology sectors. Its brands provide alkaloid extraction, refinement, and synthesis services, formulation, white-label co-packing, and marketing. It holds as intellectual property a long list of patentable trade secrets, proprietary products in development, SOPs for extraction, refinement, and synthesis, and formulations for various market-ready products. Its sales consist of natural hemp-infused products, CBD-infused products, mitragynine-infused products, kavatone infused products, products infused with various functional mushroom extracts, and products infused with a variety of minor cannabinoids.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Stock Style Box
Total Number of Employees
2

Valuation

Metric
BLEG
Price/Earnings (Normalized)
Price/Book Value
Price/Sales
Price/Cash Flow
Price/Earnings
No chart available

Financial Strength

Metric
BLEG
Quick Ratio
0.32
Current Ratio
1.50
Interest Coverage
Quick Ratio
BLEG

Profitability

Metric
BLEG
Return on Assets (Normalized)
−207.36%
Return on Equity (Normalized)
Return on Invested Capital (Normalized)
Return on Assets
BLEG
See how this stock stacks up to its competitors with Morningstar Investor

Drug Manufacturers - Specialty & Generic Industry Comparables

1-Day Chart
Name
Price
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
Merck KGaA ADR
MKKGY
KpmmzvxvlpVxbxjm$79.7 Bil
Zoetis Inc Class A
ZTS
ZykqwmtfmPbbb$78.0 Bil
Haleon PLC ADR
HLN
ZlcnwtfrsDddh$37.4 Bil
Teva Pharmaceutical Industries Ltd ADR
TEVA
GgkdlsnYrhw$18.2 Bil
Dr Reddy's Laboratories Ltd ADR
RDY
VhwltfmlzGrg$12.1 Bil
Viatris Inc
VTRS
ClmtlcrpDjyx$12.0 Bil
Catalent Inc
CTLT
SznywykJqfftx$10.0 Bil
Perrigo Co PLC
PRGO
YgbljlzzHjt$3.6 Bil
Prestige Consumer Healthcare Inc
PBH
TyppgwlgTylczqb$3.2 Bil
Curaleaf Holdings Inc
CURLF
DykhzzslbCbm$3.0 Bil

Sponsor Center